Aberdeen Centre for Evaluation (formerly HSRU)

Thrilled to welcome @nhslothian.bsky.social & @Jubilee Hospital to the @nihr.bsky.social funded EVEREST trial team! Exciting times ahead as we explore new frontiers in takotsubo research ⛰️#Research #EVERESTTrial #Takotsubo #CHaRTtrials @Dana Dawson

Happy birthday #ELIPSE! 🥳🎂
Heer Lab, Vishwanath Hanchanale, Krishna Narahari
@benchallacombe.bsky.social @jimcatto.bsky.social @bursturology.bsky.social

It’s the Edinburgh Clinical Trial Management Course next month. Great educational opportunity for those involved or interested in trial management. Supported by our own Shaun Treweek and CHaRT trial managers Kirsteen, Lynda, Suzanne and Seonaidh. clinical-research-facility.ed.ac.uk/edinburgh-cl...

We’re delighted to welcome @WWLNHS to the @NIHRresearch funded EVEREST Trial team! 🏔️Excited to work together on this important study. #Research #EVERESTTrial #Takotsubo #CHaRTtrials

Using the behavior change technique ontology to characterize the content of implementation strategies: a secondary analysis of 151 trials targeting evidence-based nursing practice AbstractBackground. Implementation strategies are essential for translating evidence into routine clinical practice. Their effectiveness depends on specify

🎉🎉Pleased to announce new publication in Translational Behavioral Medicine, our Kristin Konnyu is a co-author : Using the behavior change technique ontology to characterize the content of implementation strategies: A secondary analysis of 151 trials doi.org/10.1093/tbm/...

🏔️We’ve reached Base Camp! Recruitment for the
@nihr.bsky.social
funded EVEREST Trial is officially a go 🚦 1st Green Light issued. Here’s to scaling new heights in Takotsubo research. #EVERESTTrial #Takotsubo #CHaRTtrials
@nhsgrampian.bsky.social @dana_dawson16

AI investment to transform global policy with scientific evidence An £11.5 million AI-driven evidence synthesis project will turbocharge policymakers’ ability to quickly understand scientific evidence on important issues.

(2/2) The methods team brings leading experts from
@uniofaberdeen.bsky.social @exeter.ac.uk @newcastleuni.bsky.social @ucl.ac.uk .Transforming Global Evidence project led by @qubelfastofficial.bsky.social . For more info: bit.ly/46WNNUv

(1/2) Our Kristin Konnyu is part of one of the strand of the £11.5M @ukri.org funded Transforming Global Evidence project- Methods Work Package. The work will focus on methods development to create AI enhanced 'living #evidencesyntheses ' to inform policymakers the best evidence, more efficient.

Who is in your trial? Improving the reporting of participant characteristics in trial protocols and results - Trials

From 1st Jan 2026, the journal Trials will mandate reporting of (at least) six participant characteristics for both protocols and reports of trial results. Read more in the editorial:

trialsjournal.biomedcentral.com/articles/10....

@ukcrc-ctu.org.uk @ecrin.bsky.social

Great news from Trial Forge,
@streweek.bsky.social
and team: Journal Trials mandating the use of a tool called PRO EDI to address the gap in reporting and interpretation of equity information. More info here👉 abdn.io/1H4

One of the key things to address when undertaking a feasibility study ahead of a trial is the acceptability of different aspects of the proposed trial (intervention, trial processes, proposed outcomes etc) to all relevant parties 1/7
#MethodologyMonday #125

The six characteristics (age, sex, gender, ethnicity, socioeconomic status and location) is part of efforts to improve equity, diversity and inclusion in trials & come from our PRO EDI work (trialforge.org/trial-diversit…) 2/2

📣 Our @streweek.bsky.social is lead author on an editorial in #Trials outlining a new mandate in the journal - mandating the reporting of six key participant characteristics in any protocol/trial report submitted to Trials on or after 1st Jan 2026. 1/2
trialsjournal.biomedcentral.com/articles/10....

Great public engagement work this weekend from our amazing team 🤩

Links to papers …

Commentary:
boneandjoint.org.uk/Article/10.1...

Bayesian Re-analysis:
boneandjoint.org.uk/Article/10.1...

We are co-authors on 2 new papers in @bonejointjournal.bsky.social - one on the potential of Bayesian trials in T&O and a Bayesian reanalysis of the WHiTE8 trial.
And … our own Jemma Hudson is the featured author 😊
@docfarrow.bsky.social
@marionkcampbell.bsky.social

Links to papers below 👇

Kirsteen Goodman, the trial manager for DIETRICH (funded by @ProstateUK) is riding in the #SirChrisHoy @TourDe4
on 7 September. bit.ly/3Vqbwqq

@Krish_Narahari @jonathananing @Heer_Lab @vishhanchanale @benchallacombe @BURSTurology

There has been a lot of debate recently about the promise of real world data - the routine (observational) data collected on patients eg  treatments received, clinical outcomes etc – for estimating treatment effects. But can they deliver? 1/9
#MethodologyMonday #123

Have you registered for this year's #Edinburgh #ClinicalTrial Management Course? A 2-day course for those involved and new to #clinicalresearch | 6 & 7 Nov 2025 | Book here edin.ac/3RGb0mB #ECTMC25 @streweek.bsky.social reweek.bsky.social‬ @bleedingstroke.bsky.social @ace-aberdeen.bsky.social

Two of the key findings are:

➡️ The considerable emotional labour involved in patient feedback

➡️ Direct changes from individual feedback stories were limited but change can occur in other ways

@louiselocock.bsky.social @marionkcampbell.bsky.social @ace-aberdeen.bsky.social

A few familiar faces from @ace-aberdeen.bsky.social & #CHaRT appearing in this @uniofaberdeen.bsky.social montage from #tallshipraces2025 where we celebrated #ClinicalTrials & #JamesLind and recruited over 700 members of the public to our #LimeorBrineTrial
www.instagram.com/reel/DMrrrfJ...

2/2 ⚓️ Fun Fact Alert! Did you know we dressed as sailors at Tall Ships Aberdeen 2025 to honor Scottish James Lind, a naval surgeon who conducted first-ever clinical trial? ? 🧑‍✈️⚓️ Visitors joined the fun of trials! Yo-ho-ho! #TallShipsAberdeen

1/2 Snapshots of ACE/CHaRT at the magnificent at Tall Ships 2025⚓. Visitors have fun with our “Lime or Brine” trial! bit.ly/4lKTD1o

Secondary analysis of the Game of Stones trial for men with obesity: examining moderator effects and exploratory outcomes Objective The objective was to explore whether socioeconomic, health, and behavioral characteristics moderate the effectiveness of a text message intervention with or without financial incentives ve.....

📣 Another paper from the “Game Of Stones” randomised trial has been published! This work in the journal Obesity delves into the secondary analysis of the trial for men with obesity: examining moderator effects and exploratory outcomes. See onlinelibrary.wiley.com/doi/10.1002/...

Congratulations to Dr Shazia Yousuf as she celebrates her graduation ceremony today at the University of Aberdeen! A proud moment for all of us at the Aberdeen Centre for Evaluation. Wishing you every success, Dr Yousuf👩‍🎓 #ClassOf2025 #GraduationDay

If you are interested, please contact our researcher at m.cerar.24@abdn.ac.uk for details.

Research participants needed📢
Do you have experience recruiting patients into clinical trials in the UK and Ireland? Do you think recruitment targets are motivating? Are they communicated well? Then we would love to hear from you as a participant in our focus group study.

We contributed to the Game of Stones study that was published in JAMA last year jamanetwork.com/journals/jam.... Two of the participants have written about their experiences of taking part in research. It can be life-changing!

We marked #VolunteersWeek2025 with a special ACE event on 3 June to honour our fantastic PPI group 🎉 Delighted to be joined by the Lord Provost of Aberdeen, Prof David Blackbourn & Prof Peter Edwards. Huge thanks to all our research volunteers, study participants and PPI partners! 💙